These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23127)

  • 1. Spiperone: a ligand of choice for neuroleptic receptors. 2. Regional distribution and in vivo displacement of neuroleptic drugs.
    Laduron PM; Janssen PF; Leysen JE
    Biochem Pharmacol; 1978 Feb; 27(3):317-21. PubMed ID: 23127
    [No Abstract]   [Full Text] [Related]  

  • 2. Spiperone: a ligand of choice for neuroleptic receptors. 3. Subcellular distribution of neuroleptic drugs and their receptors in various rat brain areas.
    Laduron PM; Janssen PF; Leysen JE
    Biochem Pharmacol; 1978 Feb; 27(3):323-8. PubMed ID: 23128
    [No Abstract]   [Full Text] [Related]  

  • 3. Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding.
    Leysen JE; Gommeren W; Laduron PM
    Biochem Pharmacol; 1978 Feb; 27(3):307-16. PubMed ID: 23126
    [No Abstract]   [Full Text] [Related]  

  • 4. The low affinity component of [3H]spiperone binding reflects association to a non-dopaminergic, neuroleptic site.
    Beart PM; Krstich M; McDonald D; Gundlach AL
    Neurosci Lett; 1982 Apr; 29(2):147-51. PubMed ID: 6123968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of standard neuroleptic compounds on the binding of 3H-spiroperidol in the striatum and mesolimbic system of the rat in vitro.
    Howard JL; Large BT; Wedley S; Pullar IA
    Life Sci; 1978 Aug; 23(6):599-603. PubMed ID: 29198
    [No Abstract]   [Full Text] [Related]  

  • 6. Regional blockade by neuroleptic drugs of in vivo 3H-spiperone binding in the rat brain. Relation to blockade of apomorphine induced hyperactivity and stereotypies.
    Köhler C; Haglund L; Ogren SO; Angeby T
    J Neural Transm; 1981; 52(3):163-73. PubMed ID: 7198139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine receptors in bovine retina : characterization of the 3H-spiroperidol binding and its use for screening dopamine receptor affinity of drugs.
    Magistretti PJ; Schorderet M
    Life Sci; 1979 Nov; 25(19):1675-86. PubMed ID: 41997
    [No Abstract]   [Full Text] [Related]  

  • 8. Identity and properties of multiple neuroleptic-binding sites in rat limbic brain areas [proceedings].
    Leysen JE
    Arch Int Physiol Biochim; 1979 Oct; 87(4):822-4. PubMed ID: 93926
    [No Abstract]   [Full Text] [Related]  

  • 9. Biochemical mechanism of tolerance to neuroleptic drugs; regional differences in rat brain.
    Bacopoulos NG
    Eur J Pharmacol; 1981 Apr; 70(4):585-6. PubMed ID: 7238578
    [No Abstract]   [Full Text] [Related]  

  • 10. Similarities and dissimilarities between dopamine and neuroleptic receptors: further evidence for type 1 and type 2 dopamine receptors in the CNS.
    Spano PF; Memo M; Govoni S; Trabucchi M
    Adv Biochem Psychopharmacol; 1980; 24():113-21. PubMed ID: 6105769
    [No Abstract]   [Full Text] [Related]  

  • 11. Different kinetic properties of neuroleptic receptor binding in the rat striatum and frontal cortex.
    Leysen JE; Gommeren W
    Life Sci; 1978 Aug; 23(5):447-52. PubMed ID: 29187
    [No Abstract]   [Full Text] [Related]  

  • 12. [3H]Spiperone binding sites in brain: autoradiographic localization of multiple receptors.
    Palacios JM; Niehoff DL; Kuhar MJ
    Brain Res; 1981 Jun; 213(2):277-89. PubMed ID: 7248759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of neuroleptic receptor sites in mouse brain by autoradiography.
    Höllt V; Schubert P
    Brain Res; 1978 Jul; 151(1):149-53. PubMed ID: 679000
    [No Abstract]   [Full Text] [Related]  

  • 14. Regional localization of halopemide, a new psychotropic agent, in the rat brain.
    Loonen AJ; van Wijngaarden I; Janssen PA; Soudijn W
    Eur J Pharmacol; 1978 Aug; 50(4):403-8. PubMed ID: 29759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of a centrally active peptide on receptor macromolecular dynamics: toward a neuropsychopharmacology of phase.
    Mandell AJ
    Ann N Y Acad Sci; 1982; 398():191-206. PubMed ID: 6130735
    [No Abstract]   [Full Text] [Related]  

  • 16. Change in the charactertistics of 3H-spiperone binding to rat striatal membranes after acute chlorpromazine administration: effects of buffer washing of membranes.
    Owen F; Cross AJ; Poulter M; Waddington JL
    Life Sci; 1979 Jul; 25(4):385-90. PubMed ID: 38372
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroleptic and dopamine receptors: autoradiographic localization of [3H]spiperone in rat brain.
    Klemm N; Murrin LC; Kuhar MJ
    Brain Res; 1979 Jun; 169(1):1-9. PubMed ID: 455088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3H-Spiroperidol binding to two receptor sites in both the corpus striatum and frontal cortex of rat brain.
    Pedigo NW; Reisine TD; Fields JZ; Yamamura HI
    Eur J Pharmacol; 1978 Aug; 50(4):451-3. PubMed ID: 699968
    [No Abstract]   [Full Text] [Related]  

  • 19. [The affinity of aromatic fluoride derivatives of phenothiazine neuroleptics to spiroperidol binding sites of dopamine receptors by the radioligand technic in vitro].
    Oelssner W; Peinhardt G; Büge A
    Pharmazie; 1985 May; 40(5):341-2. PubMed ID: 2863832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of in vivo 3H-spiperone binding by the proposed antipsychotic Des-Tyr1-gamma-endorphin.
    Pedigo NW; Schallert T; Overstreet DH; Ling NC; Ragan P; Reisine TD; Yamamura HI
    Eur J Pharmacol; 1979 Dec; 60(4):359-64. PubMed ID: 43261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.